Income Statement (TTM)
China Resources Pharmaceutical Group Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 196,170 | 200,423 | 212,973 | 225,524 | 231,165 | 236,806 | 242,421 | 248,035 | 221,487 | 218,183 | 224,587 | 224,656 | 235,885 | 244,704 | 247,594 | 250,483 | 254,078 | 257,673 | 259,308 | 260,942 |
| Change (%) | 2.17 | 6.26 | 5.89 | 2.50 | 2.44 | 2.37 | 2.32 | -10.70 | -1.49 | 2.94 | 0.03 | 5.00 | 3.74 | 1.18 | 1.17 | 1.44 | 1.41 | 0.63 | 0.63 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 164,298 | 168,129 | 179,380 | 190,631 | 196,029 | 201,426 | 205,857 | 210,288 | 187,573 | 184,564 | 189,765 | 189,630 | 199,013 | 206,366 | 208,670 | 210,973 | 213,978 | 216,984 | 218,331 | 219,678 |
| Change (%) | 2.33 | 6.69 | 6.27 | 2.83 | 2.75 | 2.20 | 2.15 | -10.80 | -1.60 | 2.82 | -0.07 | 4.95 | 3.69 | 1.12 | 1.10 | 1.42 | 1.40 | 0.62 | 0.62 | |
| % of Revenue | 83.75 | 83.89 | 84.23 | 84.53 | 84.80 | 85.06 | 84.92 | 84.78 | 84.69 | 84.59 | 84.49 | 84.41 | 84.37 | 84.33 | 84.28 | 84.23 | 84.22 | 84.21 | 84.20 | 84.19 |
| Gross Operating Profit | 31,872 | 32,294 | 33,593 | 34,892 | 35,136 | 35,380 | 36,564 | 37,747 | 33,914 | 33,619 | 34,822 | 35,026 | 36,872 | 38,337 | 38,924 | 39,510 | 40,100 | 40,689 | 40,977 | 41,265 |
| Change (%) | 1.32 | 4.02 | 3.87 | 0.70 | 0.69 | 3.34 | 3.24 | -10.15 | -0.87 | 3.58 | 0.59 | 5.27 | 3.97 | 1.53 | 1.51 | 1.49 | 1.47 | 0.71 | 0.70 | |
| % of Revenue | 16.25 | 16.11 | 15.77 | 15.47 | 15.20 | 14.94 | 15.08 | 15.22 | 15.31 | 15.41 | 15.51 | 15.59 | 15.63 | 15.67 | 15.72 | 15.77 | 15.78 | 15.79 | 15.80 | 15.81 |
| SG&A | 21,842 | 21,611 | 22,651 | 23,690 | 23,741 | 23,792 | 24,306 | 24,820 | 22,247 | 21,999 | 22,783 | 22,961 | 24,227 | 25,262 | 25,420 | 25,588 | 26,077 | 26,556 | 26,943 | 27,329 |
| Change (%) | -1.06 | 4.81 | 4.59 | 0.22 | 0.22 | 2.16 | 2.12 | -10.37 | -1.11 | 3.56 | 0.78 | 5.51 | 4.27 | 0.63 | 0.66 | 1.91 | 1.84 | 1.46 | 1.43 | |
| % of Revenue | 11.13 | 10.78 | 10.64 | 10.50 | 10.27 | 10.05 | 10.03 | 10.01 | 10.04 | 10.08 | 10.14 | 10.22 | 10.27 | 10.32 | 10.27 | 10.22 | 10.26 | 10.31 | 10.39 | 10.47 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 187,445 | 191,088 | 203,465 | 215,842 | 221,402 | 226,963 | 231,990 | 237,017 | 211,624 | 208,442 | 214,407 | 214,388 | 225,168 | 233,672 | 236,294 | 238,925 | 242,312 | 245,688 | 247,435 | 249,181 |
| Change (%) | 1.94 | 6.48 | 6.08 | 2.58 | 2.51 | 2.21 | 2.17 | -10.71 | -1.50 | 2.86 | -0.01 | 5.03 | 3.78 | 1.12 | 1.11 | 1.42 | 1.39 | 0.71 | 0.71 | |
| % of Revenue | 95.55 | 95.34 | 95.54 | 95.71 | 95.78 | 95.84 | 95.70 | 95.56 | 95.55 | 95.54 | 95.47 | 95.43 | 95.46 | 95.49 | 95.44 | 95.39 | 95.37 | 95.35 | 95.42 | 95.49 |
| Operating Income | 8,726 | 9,335 | 9,509 | 9,682 | 9,762 | 9,843 | 10,430 | 11,018 | 9,863 | 9,741 | 10,180 | 10,268 | 10,717 | 11,031 | 11,300 | 11,558 | 11,766 | 11,985 | 11,873 | 11,761 |
| Change (%) | 6.99 | 1.86 | 1.82 | 0.83 | 0.83 | 5.97 | 5.63 | -10.48 | -1.24 | 4.51 | 0.86 | 4.37 | 2.94 | 2.43 | 2.28 | 1.80 | 1.86 | -0.93 | -0.94 | |
| % of Revenue | 4.45 | 4.66 | 4.46 | 4.29 | 4.22 | 4.16 | 4.30 | 4.44 | 4.45 | 4.46 | 4.53 | 4.57 | 4.54 | 4.51 | 4.56 | 4.61 | 4.63 | 4.65 | 4.58 | 4.51 |
| Interest Expense | -3,333 | -3,135 | -3,087 | -3,040 | -2,875 | -2,711 | -2,655 | -2,600 | -2,392 | -2,428 | -2,551 | -2,606 | -2,497 | -2,363 | -2,237 | -2,112 | -2,187 | -2,262 | -2,176 | -2,091 |
| Change (%) | -5.95 | -1.51 | -1.54 | -5.41 | -5.71 | -2.06 | -2.10 | -7.99 | 1.50 | 5.07 | 2.16 | -4.17 | -5.39 | -5.31 | -5.61 | 3.55 | 3.43 | -3.78 | -3.93 | |
| % of Revenue | -1.70 | -1.56 | -1.45 | -1.35 | -1.24 | -1.14 | -1.10 | -1.05 | -1.08 | -1.11 | -1.14 | -1.16 | -1.06 | -0.97 | -0.90 | -0.84 | -0.86 | -0.88 | -0.84 | -0.80 |
| Net Income | 3,063 | 3,297 | 3,228 | 3,158 | 3,463 | 3,769 | 4,062 | 4,356 | 3,724 | 3,500 | 3,518 | 3,382 | 3,647 | 3,854 | 3,816 | 3,777 | 3,564 | 3,351 | 3,087 | 2,823 |
| Change (%) | 7.65 | -2.11 | -2.15 | 9.67 | 8.82 | 7.79 | 7.22 | -14.51 | -6.01 | 0.49 | -3.84 | 7.83 | 5.67 | -1.00 | -1.01 | -5.65 | -5.98 | -7.87 | -8.54 | |
| % of Revenue | 1.56 | 1.65 | 1.52 | 1.40 | 1.50 | 1.59 | 1.68 | 1.76 | 1.68 | 1.60 | 1.57 | 1.51 | 1.55 | 1.58 | 1.54 | 1.51 | 1.40 | 1.30 | 1.19 | 1.08 |
Source: Capital IQ
